• Services
    Applications Artificial & Augmented Intelligence Business Process Business Solutions Cloud
    Consulting Cybersecurity Data & Analytics Design & Experience Digital Marketing & Interaction
    Engineering Infrastructure Sustainability Talent Cloud
  • Industries
    Aerospace & Defense Automotive Banking Capital Markets Communications Consumer Electronics Consumer Packaged Goods
    Education Engineering Construction & Operations Healthcare Industrial & Process Manufacturing Insurance Life Sciences & Pharma
    Media & Info Services Medical Devices Natural Resources Network & Edge Providers Oil & Gas Platforms & Software Products Professional Services
    Public Sector Retail Semiconductors Transportation & Services Utilities
  • Insights
    Featured Insights From our CEO Business Strategy Digital Transformation Sustainability Technology Trends
  • About Wipro
    About Us Analyst Speak Awards and Recognitions Events Inclusion and Diversity Investors
    Lab45 Leadership Locations News Partner Ecosystem Sustainability
    The Story of Wipro Privacy at Wipro Supplier Diversity Wipro Ventures
  • Careers
  • Contact Us
Locations

America

country brazil Brazil En Po

country canada Canada

country latam Latam

country maxicoMexico En Sp

country usa United States

Europe En De

country benelux Benelux

country dach Germany & Austria En De

country nordic Nordic

country france Southern Europe En Fr

country switzerland Switzerland En De

United Kingdom & Ireland

Asia Pacific

countryAsean

countryAustralia & New Zealand

countryChina

countryJapan En Jp

countryKorea

countryTaiwan

India & Middle East

country IndiaIndia

countryMiddle East

Africa

countryGlobal Site

< Insights

Pranab Gogoi

comments.png liked.png share icon
comments.png liked.png

Pranab Gogoi

Pranab’s overall experience of ~spans over 21 years across Labeling Artwork Lifecycle Management in the pharmaceutical and lLife sciences industryies regulatory domain. He has wWorked for Mmajor Llife sesciences Cconsulting firms and havehas catered to customers such as Novartis, GSK, and Apotex, etc. as a rRegulatory SME. He has also sSuccessfully transitioned Ppharmaceutical regulatory processes and projects, implemented related technology and established quality management including audit preparedness and SOP writing.

Blogs By Author

blog image

Manage Risks with Quality Control Process for artworks in life sciences Industry

Let’s start with a case study. A mid-sized pharmaceutical company, engaged in packaging artwork management and artwork studio services, did not deploy artwork proofreading system at the artwork studio level, though it had an electronic proofreading system in review and approval stage for the Regulatory Affairs (RA) team. Due to this structure, the approval process to finalize an artwork was long and tedious. Any error introduced by the artwork studio was picked at the review and approval stage, further adding time to the artwork approval process and increasing the number of versions.

January 11, 2022
blog image

E-Labelling: A regulatory mandate ensuring ease of business

Label and artwork management in medical device companies are still seen as an afterthought and therefore, there is not enough concentration as well as investment in this area. However, with new updates such as traceability (UDI) and e-labeling, companies are compelled to invest time and money to be compliant on the regulations required.

January 11, 2022
© 2023 Wipro
Disclaimer Privacy
X

Share Icon
popup-image

Contact Wipro

Please fill the required details to access the content

loading.gif